Most Recent

Single-cell analyses from mouse samples detail the changes in cell distribution during infections.


Maintaining dynamic connections among the body’s mitochondria is required for the health and life-extending benefits of low-calorie diets for nematodes.


image: Mass Resignation from <em>Scientific Reports</em>’s Editorial Board

Mass Resignation from Scientific Reports’s Editorial Board

By Catherine Offord | November 7, 2017

Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.


image: Corals’ pH Sensor Identified

Corals’ pH Sensor Identified

By Ashley P. Taylor | November 1, 2017

Soluble adenylyl cyclase measures and responds to pH changes in coral cells, but whether it can help the animals withstand ocean acidification is not yet known.


image: Opinion: How to Define Cell Type

Opinion: How to Define Cell Type

By Sara B. Linker, Tracy A. Bedrosian, and Fred H. Gage | November 1, 2017

Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.


image: Infographic: Breaking into the Brain

Infographic: Breaking into the Brain

By Amanda B. Keener | November 1, 2017

The blood-brain barrier is a collection of specialized cells and proteins that control the movement of molecules from the blood to the central nervous system.


image: Getting Drugs Past the Blood-Brain Barrier

Getting Drugs Past the Blood-Brain Barrier

By Amanda B. Keener | November 1, 2017

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.


Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 


Popular Now

  1. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  2. University of Oregon Erecting a $1-Billion Science Center
  3. Investigation Finds Signs of Misconduct in Swedish Researcher’s Papers
  4. Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test